Noninvasive assessment of characteristics of novel anti-HER2

Therapeutic strategy for anti-Her2 and Palbociclib resistant tumors

HER2 targeted noninvasive immunosensor based on pencil graphite electrode for detection of breast cancer - ScienceDirect

Cancers, Free Full-Text

Cancers, Free Full-Text

Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with 18F-FDG and 89Zr-Trastuzumab PET

Frontiers Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis

Frontiers Cardiotoxicity from neoadjuvant targeted treatment for breast cancer prior to surgery

Summary of bioinformatics analysis that were used for HER2 peptide

Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer